Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001574522-13-000001
Filing Date
2013-04-18
Accepted
2013-04-18 15:02:04
Documents
1
Effectiveness Date
2013-04-18
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8403
  Complete submission text file 0001574522-13-000001.txt   9408
Mailing Address 11 BYRON STREET BOSTON MA 02108
Business Address 11 BYRON STREET BOSTON MA 02108 212-568-4614
Aggamin Pharmaceuticals, LLC (Filer) CIK: 0001574522 (see all company filings)

EIN.: 271108491 | State of Incorp.: MA | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-195212 | Film No.: 13769070